Hospital leaders expect case volume of flu, the common cold, and respiratory syncytial virus, RSV, to keep climbing.
State and federal data show high levels of respiratory illnesses. Here's what to know about the illnesses circulating this ...
Eight in 10 infants received respiratory syncytial virus (RSV) protection during the 2023 to 2024 season, according to a ...
In China, reports of HMPV infections have indeed been rising in recent weeks in the more northerly regions. But so have ...
For immunocompromised individuals, antibody response to RSV vaccines is heterogeneous and about 40% do not seroconvert.
The term ‘Quad-demic’ is used to describe a situation where four respiratory illnesses – Covid-19, influenza, norovirus and ...
A GP has told how RSV symptoms can be “easily mistaken” for a cold – and revealed when it’s time to call an ambulance for ...
Two suspected cases of Human Metapneumovirus (HMPV) have been reported in Nagpur, Maharashtra, raising concerns about the ...
An 80-year-old man tested positive for human metapneumovirus (HMPV) infection in Ahmedabad city of Gujarat on Thursday, ...
The FDA has mandated updated safety labeling for two respiratory syncytial virus vaccines, Pfizer's Abrysvo and GlaxoSmithKline's Arexvy, following the identification of an increased risk of ...
The Wall Street Journal on MSN3h
Health Care Roundup: Market Talk
Read about vaccine sales, Akums and more in the latest Market Talks covering Health Care.